Skip to main content
NIH funding notice PAR-25-337

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)

Open. Closes January 7, 2028.

Posted
December 31, 2024
Close date
January 7, 2028
Activity codes
R01
Institutes taking part
NCI

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

  1. Reissues: PAR-21-206 Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)

Who won it before

14 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,042,077 in first-year total cost, median $610,197.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 CTH-E (57)]6
  2. Special Emphasis Panel[ZRG1 ISB-S (57)]3
  3. Special Emphasis Panel[ZRG1 SBIB-Q (57)]2
  4. Special Emphasis Panel[ZRG1 SBIB-S (57)]2
  5. Special Emphasis Panel[ZRG1 ISB-J (57)]1

Most frequent institutions

  1. JOHNS HOPKINS UNIVERSITY3
  2. BRIGHAM AND WOMEN'S HOSPITAL2
  3. BASIC HEALTH INTERNATIONAL, INC.1
  4. BAYLOR COLLEGE OF MEDICINE1
  5. INDIANA UNIVERSITY INDIANAPOLIS1
Competing awards under PAR-25-337 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Lymph Node Quantification System for Multisite Clinical Trials2R01CA235589-06A1 · under PAR-21-206HARRIS, GORDON JKIKINIS, RONBRIGHAM AND WOMEN'S HOSPITAL, MA$703,707ZRG1
2025Development and optimization of highly effective treatments in patients with head and neck cancer using in situ implantable microdevices1R01CA295683-01 · under PAR-21-206JONAS, OLIVERBRIGHAM AND WOMEN'S HOSPITAL, MA$703,540ZRG1
2025Image-guided ethyl cellulose ethanol ablation to enable treatment of cervical dysplasia in low and middle-income countries1R37CA302885-01 · under PAR-21-206MUELLER, JENNA LYNNE HOOKUNIV OF MARYLAND, COLLEGE PARK, MD$627,148ZRG1
2024Cue-101 and TCR-T cell Combinatorial Strategy for HPV+ Head and Neck Cancers1R01CA278212-01A1 · under PAR-21-206PAI, SARA ISABELYALE UNIVERSITY, CT$691,530ZRG1
2024Translating buccal nanocytology for lung cancer screening into clinical practice2R01CA225002-07A1 · under PAR-21-206BACKMAN, VADIMBHARAT, ANKITSUBRAMANIAN, HARIHARANNORTHWESTERN UNIVERSITY, IL$682,587ZRG1
2024Adapting flow cytometry methods for early detection of acute hematologic malignancies in Kenya including the improvement of sample flow processes and technical training of personnel1R01CA278862-01A1 · under PAR-21-206VIK, TERRY AINDIANA UNIVERSITY INDIANAPOLIS, IN$521,488ZRG1
2024POINT of CARE: PrOviding an Innovative New Triage and Treatment strategy for Cervical cAncer scReening Efficiency1R01CA285369-01A1 · under PAR-21-206ALFARO, KARLAMASCH, RACHELBASIC HEALTH INTERNATIONAL, INC., PA$481,280ZRG1
2023Development of an automated, point of care DNA methylation cartridge blood test for colorectal cancer detection in LMICs- an academic-industrial partnership1R01CA278816-01 · under PAR-21-206SUKUMAR, SARASWATIJOHNS HOPKINS UNIVERSITY, MD$618,843ZRG1
2023Validation and Translation of MasSpec Pen Technology for Intraoperative Evaluation of Non-small Cell Lung Cancer1R01CA284742-01 · under PAR-21-206BURT, BRYAN MICHAELSCHIAVINATO EBERLIN, LIVIAWISEMAN, JUSTINBAYLOR COLLEGE OF MEDICINE, TX$601,550ZRG1
2023TGX-1214 - Combination Strategy for the Treatment of Advanced Pancreatic Cancer1R01CA269233-01A1 · under PAR-21-206AMIJI, MANSOOR M.EGAN, JAMES EKIM, EDWARD JMACKENZIE, GERARDO GUILLERMOUNIVERSITY OF CALIFORNIA AT DAVIS, CA$583,071ZRG1
2023A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs1R37CA275824-01 · under PAR-21-206BASU, PARTHAINTERNATIONAL AGENCY FOR RES ON CANCER$519,313ZRG1
2023dMRI-guided pre-operative planning for supra-total resection of high-grade gliomas1R01CA278819-01 · under PAR-21-206HADJIPANAYIS, CONSTANTINOS GEORGEHODGES, WESLEY BRYANVERMA, RAGINIUNIVERSITY OF PENNSYLVANIA, PA$87,775ZRG1
2022Clinical translation of a PD-L1 PET tracer to optimize immune checkpoint therapy in patients with non-small cell lung cancers1R01CA269235-01 · under PAR-21-206NIMMAGADDA, SRIDHARROWE, STEVEN PJOHNS HOPKINS UNIVERSITY, MD$624,800ZRG1
2022DEVELOPMENT OF AN AUTOMATED CARTRIDGE-BASED BREAST CANCER DETECTION ASSAY- AN ACADEMIC-INDUSTRIAL PARTNERSHIP1R01CA269237-01 · under PAR-21-206SUKUMAR, SARASWATIJOHNS HOPKINS UNIVERSITY, MD$595,445ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.